Archive for UCNT

PROMISE Registry: A Prostate Cancer Registry of Outcomes and Germline Mutations for Improved Survival and Treatment Effectiveness

An Open-Label, Phase 1/1b Study of ORIC-944 in Patients with Metastatic Prostate Cancer

A Phase 1, open-label trial of belzupacap sarotalocan (AU-011) to determine the feasibility and safety of intratumoral injection with or without intramural injection in subjects with bladder cancer